Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation
- PMID: 18451331
- PMCID: PMC2748384
- DOI: 10.1161/ATVBAHA.108.167437
Polymorphisms of the IL1-receptor antagonist gene (IL1RN) are associated with multiple markers of systemic inflammation
Abstract
Background: Circulating levels of acute phase reactant proteins such as plasma C-reactive protein (CRP) are likely influenced by multiple genes regulating the innate immune response.
Methods and results: We screened a set of 16 inflammation-related genes for association with CRP in a large population-based study of healthy young adults (n=1627). Results were validated in 2 independent studies (n=1208 and n=4310), including a pooled analysis of all 3 studies. In the pooled analysis, the minor allele of IL1RN 1018 (rs4251961) within the gene encoding interleukin (IL)-1 receptor antagonist (IL-1RA) was significantly associated with higher mean plasma log(CRP) level (P<1 x 10(-4)). The same IL1RN 1018 allele was associated with higher mean plasma log(IL-6) levels (P=0.004). In the pooled analysis, the minor allele of IL1RN 13888 (rs2232354) was associated with higher fibrinogen, (P=0.001). The IL1RN 1018 and 13888 variant alleles tag a clade of IL1RN haplotypes linked to allele 1 of an 86-bp VNTR polymorphism. We confirmed that the IL1RN 1018 variant (rs4251961) was associated with decreased cellular IL-1RA production ex vivo.
Conclusions: Common functional polymorphisms of the IL1RN gene are associated with several markers of systemic inflammation.
References
-
- Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med. 1999;340:448–454. - PubMed
-
- Pearson TA, Mensah GA, Hong Y, Smith SC., Jr CDC; AHA. CDC/AHA Workshop on Markers of Inflammation and Cardiovascular Disease: Application to Clinical and Public Health Practice: overview. Circulation. 2004;110:e543–e544. - PubMed
-
- Ganapathi MK, Rzewnicki D, Samols D, Jiang SL, Kushner I. Effect of combinations of cytokines and hormones on synthesis of serum amyloid A and C-reactive protein in Hep 3B cells. J. Immunol. 1992;147:1261–1265. - PubMed
-
- Mackiewicz A, Speroff T, Ganapathi MK, Kushner I. Effects of cytokine combinations on acute phase protein production in two human hepatoma cell lines. J Immunol. 1991;146:3032–3037. - PubMed
-
- Agrawal A, Samols D, Kushner I. Transcription factor c-Rel enhances C-reactive protein expression by facilitating the binding of C/EBPbeta to the promoter. Mol Immunol. 2003;40:373–380. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- N01 HC095095/HL/NHLBI NIH HHS/United States
- N01-HC-85085/HC/NHLBI NIH HHS/United States
- N01-HC-85081/HC/NHLBI NIH HHS/United States
- N01-HC-85086/HC/NHLBI NIH HHS/United States
- N01-HC-48050/HC/NHLBI NIH HHS/United States
- N01-HC-85082/HC/NHLBI NIH HHS/United States
- N01 HC-55222/HC/NHLBI NIH HHS/United States
- N01-HC-48049/HC/NHLBI NIH HHS/United States
- N01 HV048195/HL/NHLBI NIH HHS/United States
- N01 HC048050/HL/NHLBI NIH HHS/United States
- N01-HC-85079/HC/NHLBI NIH HHS/United States
- N01 HC035129/HC/NHLBI NIH HHS/United States
- R01 HL071017/HL/NHLBI NIH HHS/United States
- N01-HC-05187/HC/NHLBI NIH HHS/United States
- N01 HC048048/HL/NHLBI NIH HHS/United States
- N01-HV-48195/HV/NHLBI NIH HHS/United States
- N01 HG065403/HG/NHGRI NIH HHS/United States
- U01 HL080295/HL/NHLBI NIH HHS/United States
- N01-HC-48047/HC/NHLBI NIH HHS/United States
- U19 AG023122/AG/NIA NIH HHS/United States
- R01 HL073401/HL/NHLBI NIH HHS/United States
- N01 HC015103/HC/NHLBI NIH HHS/United States
- N01 HC085086/HL/NHLBI NIH HHS/United States
- N01 HC048049/HL/NHLBI NIH HHS/United States
- R01 HL-071862/HL/NHLBI NIH HHS/United States
- R01 AG 027236/AG/NIA NIH HHS/United States
- U01 HL66682/HL/NHLBI NIH HHS/United States
- N01-HC-95095/HC/NHLBI NIH HHS/United States
- R01HL67406/HL/NHLBI NIH HHS/United States
- N01 HC055222/HL/NHLBI NIH HHS/United States
- R01 HL067406/HL/NHLBI NIH HHS/United States
- N01-HC-85083/HC/NHLBI NIH HHS/United States
- N01-HC-75150/HC/NHLBI NIH HHS/United States
- N01 HC045134/HC/NHLBI NIH HHS/United States
- N01-HC-85080/HC/NHLBI NIH HHS/United States
- R01 HL071862/HL/NHLBI NIH HHS/United States
- N01 HC005187/HL/NHLBI NIH HHS/United States
- N01 HC085079/HL/NHLBI NIH HHS/United States
- N01 HC048047/HL/NHLBI NIH HHS/United States
- NIH R01HL67406/HL/NHLBI NIH HHS/United States
- N01-HC-48048/HC/NHLBI NIH HHS/United States
- P01 HL072262/HL/NHLBI NIH HHS/United States
- N01 HC075150/HL/NHLBI NIH HHS/United States
- R01 HL089807/HL/NHLBI NIH HHS/United States
- N01 HC045133/HC/NHLBI NIH HHS/United States
- R01 HL074366/HL/NHLBI NIH HHS/United States
- U01 HL066682/HL/NHLBI NIH HHS/United States
- N01-HC-85084/HC/NHLBI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous